Israeli state-owned defense company Tomer has signed a five-year, $830 million agreement to supply the U.S. Army with 155-millimeter artillery shells as Washington struggles to meet its monthly ammunition production target, Israeli newspaper Haaretz reported.
The contract covers artillery shells classified as Explosive Advanced Submunitions, which contain dozens of smaller explosives designed to strike multiple targets, according to U.S. authorities.
The cluster-type munitions are reportedly designed to eliminate the risk of unexploded submunitions remaining on the ground after deployment, a claim highlighted in the Haaretz report.
The agreement is part of Washington's efforts to secure a monthly supply of 100,000 artillery shells.
According to Haaretz, the U.S. has faced difficulties reaching its target of producing 100,000 artillery shells per month.
The report recalled that Washington shipped tens of thousands of artillery shells to Israel during the early stages of Israel's military offensive in Gaza, which began in October 2023.
Production setbacks have also affected U.S. ammunition manufacturing facilities.
A plant in Texas, which received approximately $500 million in U.S. government funding, experienced prolonged production shutdowns last summer due to equipment malfunctions, uncontrolled robotic arms and fires, the newspaper reported.
Tomer primarily manufactures engines for Arrow missile systems, satellite launch vehicles, guided missiles and artillery rockets.
The company operates three facilities in central and southern Israel and is expected to generate $261 million in revenue this year.
According to Haaretz, that would represent an increase of approximately 40% compared with 2025, when the company's net profit margin reached 6.3%.
The five-year U.S. Army contract represents a major artillery ammunition supply agreement for the Israeli defense manufacturer as Washington seeks to expand its production capacity.